A new study indicates that dietary fiber's effectiveness in managing celiac disease may rely on the presence of specific gut microbes capable of metabolizing it. This suggests the need for more personalized dietary strategies for those adhering to a gluten-free diet.
Read More
Celiac disease (CeD) is an inflammatory condition that primarily affects the small intestine, often triggered by dietary gluten in genetically susceptible individuals. This condition leads to immune responses that damage the intestinal lining, impair nutrient absorption, and can result in various gastrointestinal symptoms. Patients diagnosed with CeD must follow a strict gluten-free diet, which, while essential, may lack adequate fiber and lead to nutritional deficiencies.
Despite recommendations for increased fiber consumption, a study led by Mark Wulczynski at McMaster University has unveiled that the benefits of fiber may be contingent upon the presence of specific microbial communities in the gut. The research team analyzed duodenal samples from three participant groups: newly diagnosed individuals on unrestricted diets, treated patients who had been gluten-free for at least two years, and controls without celiac disease.
The findings revealed a significant reduction in bacteria from the Prevotellaceae family, which play a crucial role in fiber degradation, in both CeD groups. This reduction corresponded with lower fiber-degrading enzyme activity in the small intestine.
Most current dietary guidelines recommend a fiber intake of 25 to 38 grams per day, but individuals on a gluten-free diet often fall short. The study highlighted that dietary fibers alone may not rectify the microbial imbalances present at the time of diagnosis, which do not fully recover even after long-term adherence to gluten-free protocols.
In preclinical models, the presence of specific fiber-degrading bacteria was essential for the production of beneficial metabolites from fiber. Different types of fiber also showed varying effects on gut health. For example, inulin, a fermentable fiber, enhanced gut microbiota activity and promoted intestinal healing, while another fiber, Hylon VII, did not yield similar benefits, despite both being classified as prebiotics.
The results underscore that merely increasing fiber intake is insufficient without addressing the corresponding microbial communities capable of metabolizing it. This research shifts the focus toward tailored nutritional approaches that recognize the influence of gut microbiota on dietary interventions for celiac disease.
The study was conducted at the Farncombe Family Digestive Health Research Institute under Dr. Elena Verdu's leadership, with Wulczynski receiving funding from the Canadian Institutes of Health Research.